The aim of this systematic review was to assess the effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on postoperative renal function. Eight randomized placebo-controlled double-blinded trials (n=345) were identified from searches of MEDLINE, EMBASE and the Cochrane Controlled Trials Register databases. The summary effect size and 95% confidence intervals (95%CI) were calculated by a weighted mean difference analysis using a randomeffects model. The NSAIDs (diclofenac, ketorolac, indomethacin, ibuprofen) were used for up to three days after surgery. There were no reported cases of postoperative renal failure requiring dialysis. NSAIDs reduced creatinine clearance by 22 ml.min -1 (95%CI: 7 to 37), sodium output by 54 mmol.day -1 (95%CI: 5 to 103) and potassium output by 38 mmol.day -1 (95%CI: 19 to 56) on Day 1 but not on Day 2. Serum creatinine increased on Day 2 by 15µmol.l -1 (95%CI: 2 to 28). Urine volume did not change significantly at any time. There was therefore a clinically unimportant transient reduction in renal function. NSAIDs should not be withheld from patients with normal preoperative renal function because of concerns about postoperative renal impairment.
Optimal postoperative pain management can include the selective use of nonsteroidal antiinflammatory drugs (NSAIDs) with or without supplemental opioids. The Royal College of Anaesthetists recently published Guidelines for the use of nonsteroidal anti-inflammatory drugs in the perioperative period, an overview of the benefits and risks of using NSAIDs 1 . It concluded that in patients who had undergone major surgery, NSAIDs were not sufficiently effective as the sole agent and that renal function should be monitored regularly in these patients and in at-risk patients 1 .
The perioperative use of NSAIDs may be limited because of concern with side-effects relating to the gastrointestinal, coagulation and renal systems [2] [3] [4] . Recent attention has been given to the possibility of renal toxicity caused by the use of NSAIDs during the perioperative period 5 . NSAIDs may produce either acute, reversible or permanent renal toxicity and a variety of effects on electrolyte and water homeostasis 6 . The most important renal complication after surgery is acute renal failure. Acute renal failure is characterized by a deterioration of renal function over a period of hours to days, resulting in the failure of the kidney to excrete nitrogenous waste products and to maintain fluid and electrolyte homeostasis 7 . Morbidity and mortality are closely associated with postoperative acute renal failure 8 . While the definition of acute renal failure and renal insufficiency varies among studies, one study showed that the overall incidence of postoperative renal insufficiency was 18% after major surgery, with a subsequent hospital mortality rate of 13% 9 .
Although there have been case reports describing adverse renal effects of NSAIDs 10, 11 , the evidence from randomized controlled trials is inconclusive. Several such studies [12] [13] [14] [15] showed that NSAIDs caused changes in electrolyte balance and urine output. In contrast, others have failed to show any significant effect of NSAIDS on renal function [16] [17] [18] [19] . In some of these trials, the results may have been imprecise because the sample size was insufficient to detect important differences. Therefore, it is unclear whether there is a clinically significant effect of NSAIDs on renal function.
By combining the results of several studies identified from a systematic approach to literature retrieval, increased precision in quantifying the adverse renal effects of NSAIDs and identification of potential sources of variability in study results can be obtained. The aim of this systematic review was to assess the effects of NSAIDs on postoperative renal function.
METHODS

Study selection
One author (AL) searched MEDLINE (January 1966-June 1998) and EMBASE (January 1988-June 1998) databases for placebo controlled trials examining the adverse renal effects of NSAIDs. There was no language restriction placed on the searches. An "optimally sensitive search" strategy to find randomized controlled trials 20 was used in conjunction with the MESH and text words "nonsteroidal antiinflammatory agents", "kidney failure", and "postoperative". Additional trials were identified from reference lists of retrieved papers, review articles and the Cochrane Controlled Trials Register. Two authors (AL, MC) independently identified the trials for inclusion in the systematic review.
Quality assessment
To rate the quality of retrieved articles, a reliable and validated five point scale was used 21 . Points were given for details about appropriate randomization, double-blinding and number and reasons for withdrawals. The minimum and maximum score for an included study were one and five respectively. High quality studies were defined as those studies scoring greater than two. Low quality studies were defined as those studies scoring two or less 22 . The level of allocation concealment (i.e. the process used to prevent foreknowledge of group assignment in a randomized controlled trial) was graded as adequate, unclear or inadequate 23 .
Data extraction
Data was abstracted independently by the authors (AL, MC) using a standardized data collection form. An intraclass correlation coefficient for the study quality was calculated using an analysis of variance method to assess agreement between the authors 24 . The raters met to agree on consensus scores and inclusion of studies for the meta-analyses. Disagreement was resolved by a third author (JC). Trials were examined for duplicate data but none occurred.
The duration of treatment, type of and dose of NSAIDs, patient population, type of surgery, and anaesthetic details were recorded. The primary outcome was creatinine clearance on Day 1 and Day 2 after surgery. A creatinine clearance reduction of 50% was chosen as the threshold for a clinically important change.
Other outcomes collected on Day 1 and Day 2 after surgery were serum creatinine, urine volume, urinary sodium and potassium levels, fractional excretion of sodium and potassium, need for dialysis and diuretic treatment for renal insufficiency. These outcomes measures were defined before data extraction and were patient-centred outcomes of clinical importance. If the article reported measurements taken at multiple time points, the values at or near 24 or 48 hours after surgery were selected for analyses, because the 24 and 48 hour time points were most often reported in these studies.
Statistical analysis
The DerSimonian and Laird random-effects model was used to combine data for both continuous and dichotomous outcomes, because we expected that the treatments and conditions in these studies would be heterogeneous 25 . This model incorporates both between-study (different treatment effects) and within-study (sampling error) variability 26 . The pooled relative risk (RR) and 95% confidence interval (95% CI) were calculated for dichotomous data (need for dialysis and diuretic treatment for renal insufficiency).
For continuous outcomes, the mean and standard deviation for each treatment group before and after the operation were collected. As the correlation coefficient between preoperative and postoperative measures was unknown, we assumed a correlation of 0.50 27 . The standard deviation between preoperative and postoperative measures for each treatment group was estimated using a method outlined in the Cochrane Collaboration Handbook 20 .
For each continuous outcome, the mean difference in each study was defined: mean difference=[NSAIDs (post-pre)] -[Placebo (post-pre)] where "post" represented a postoperative measure and "pre" represented a preoperative measure. A postoperative measure was either at Day 1 or Day 2 after surgery. A weighted mean difference method was used to pool continuous data for each of the following outcomes: creatinine clearance, serum creatinine, urine volume, sodium output, potassium output, fractional excretion of sodium and fractional excretion of potassium. These were analysed separately for Day 1 and Day 2. These results are reported as weighted mean difference and 95% CI.
The χ 2 test for heterogeneity (α=0.10) was used to assess the effect-size variability among the trials. Where heterogeneity (inter-study variation) was found, the studies that seemed to be the major contributors to the heterogeneity were evaluated in an attempt to discover the reasons. Subgroup analyses were done to estimate the robustness of results according to allocation concealment (adequate versus unclear/inadequate), study quality (high versus low) and the type of NSAIDs given. All calculations were performed using the Arcus Quickstat program (Arcus Quickstat Biomedical version 1.1; Research Solutions, Cambridge, U.K. 1998).
RESULTS
Description of trials
From the 21 articles potentially fulfilling the entry criteria, 12 were identified as randomized controlled trials. One of these was excluded because oliguria was not defined 28 . In another 29 , NSAIDs were administered two days after cardiac surgery to treat postpericardiotomy syndrome. Castiglione's trial 30 was also excluded because it compared both preoperative and postoperative ketorolac administration with postoperative ketorolac administration and there was no placebo or control group. Although one study examined the effect of diclofenac on intraoperative renal blood flow and glomerular filtration rate, it was excluded because postoperative outcomes were not collected 31 .
The remaining eight trials (n=345) were randomized, placebo-controlled and double-blinded trials of parallel-arm design ( Table 1 ). The trials were conducted between 1992 and 1999. The number of participants varied from 20 to 100, with a median of 30. The participants were all adults (23 to 79 years) with normal preoperative renal function ( Table 1) . All trials except one 15 included both males and females undergoing various types of surgery. All patients underwent general anaesthesia, with additional regional anaesthesia in two studies 13, 18 . All studies were published in English.
There was high reliability (0.82) between the two authors in judging the quality of the studies. The quality of studies was high, scoring between 3 and 5. The method of allocation concealment was unclear [12] [13] [14] [15] 17, 18 in six trials and adequate in two 16, 19 . For all trials, withdrawals were few (<10%).
The NSAIDs used in these studies were diclofenac [13] [14] [15] 19 , ketorolac 12, 17, 19 , indomethacin 16 and ibuprofen 18 . The route of administration, dose given and duration of diclofenac and ketorolac treatment varied between studies (Table 1 ). Aitken's study 12 had two active treatment arms (continuous and intermittent ketorolac) which were analysed separately in the following meta-analysis. In another study 19 , intravenous diclofenac and ketorolac groups were analysed separately. No studies described preoperative hydration treatment.
Renal function outcomes
All studies pooled for analysis were homogeneous. There were no reported cases of postoperative renal failure requiring dialysis. The pooled risk of renal insufficiency requiring postoperative frusemide treatment for two studies 14, 18 was no greater in the NSAIDs group than the placebo group (RR=1.52, 95% CI: 0.68 to 3.36). Dopamine was routinely given to all patients undergoing infrarenal abdominal aortic surgery 18 . In another study 14 , one patient in the diclofenac group was given dopamine and frusemide for postoperative renal insufficiency but subsequent analysis showed that this patient had pre-existing renal impairment.
When creatinine clearance was pooled from all trials, NSAIDs reduced creatinine clearance by 22 ml.min -1 (95% CI: 7 to 37) on Day 1 (Figure 1 ). On Day 2, there was no significant reduction ( Figure 1 ). When Aitken's 12 continuous ketorolac arm was used instead of the intermittent ketorolac arm in the above meta-analysis, NSAIDs reduced creatinine clearance by 17 ml.min -1 (95% CI: 3 to 32) on Day 1, with no significant reduction on Day 2 (1 ml.min -1 , 95% CI: -30 to 32). Table 2 shows the other renal function outcomes for Day 1 and Day 2. NSAIDs did not reduce urine volume on Day 1 (P=0.07) or on Day 2. Although there was no significant difference in serum creatinine between NSAIDs and placebo on Day 1, there was an increase on Day 2 ( Table 2 ). NSAIDs reduced sodium and potassium output on Day 1, but not on Day 2. The reductions in fractional sodium and potassium excretion were not significant on Day 1. Although Irwin and colleagues 15 collected fractional sodium and potassium excretion on Day 2, it was not included in the Day 2 analysis because diclofenac was not given. Subgroup analyses were not performed for urine volume, sodium and potassium output and fractional sodium and potassium excretion as all the relevant studies [12] [13] [14] [15] 18 had unclear allocation concealment and were of high study quality. In the two studies 13, 14 with unclear methods of allocation concealment, there was no significant increase in serum creatinine on Day 1 (-1 µmol.l -1 , 95% CI: -12 to 10) or on Day 2 (6 µmol.l -1 , 95% CI: -30 to 42). In contrast, Perttunen et al's study 19 had an adequate method of allocation concealment and showed that serum creatinine was only significantly higher in the NSAIDs group than placebo on Day 2 (16 µmol.l -1 , 95% CI: 2 to 30) on Day 2. We were unable to perform subgroup analyses for individual types of NSAIDs because there were insufficient numbers of studies with common outcomes to do so.
DISCUSSION
This systematic review has shown that NSAIDs caused a clinically unimportant reduction in renal function on the first day after surgery in patients with normal preoperative renal function. The reduction in creatinine clearance on the first day by NSAIDs was between 21% and 28% (mean baseline creatinine clearance was approximately 80 ml.min -1 ). The fact that this reduction did not affect urine volume or that no patient required dialysis confirms that it is clinically unimportant. We noted that one patient with pre-existing renal disease received both frusemide and dopamine for the treatment of renal insufficiency, probably caused by the use of diclofenac 14 . The reduction in creatinine clearance by NSAIDs on the second day after surgery was small (0% to 9%) and was not significantly different from placebo. The only important finding on the second day was that there was an increase in serum creatinine. As creatinine clearance decreased, the half-life of serum creatinine increased, taking a day to reach a new equilibrium 32 .
We found transient postoperative creatinine clearance and electrolyte homeostasis disturbances attributed to the use of NSAIDs. The mechanism by which NSAIDs affect the renal system is complex. Inhibition of prostaglandin synthesis by NSAIDs can decrease distal tubular flow rate and sodium delivery by reducing the glomerular filtration rate and increasing tubular reabsorption of sodium 33 . Inhibition of prostaglandins leads to a moderate decline in aldosterone, which may contribute to potassium retention 33 .
There are two possible factors which may explain the transient reductions in renal function seen in this systematic review. First, renal prostaglandins (PGI 2 ) may be involved in maintaining renal function for up to one day after surgery, but thereafter their importance may be diminished 14 . Second, the effect on the kidneys from the surgery itself and the subsequent recovery period may have been of much greater magnitude than any NSAIDs-induced effect 12 .
We found no strong evidence that NSAIDs caused postoperative renal failure in adults with normal preoperative renal function. None of the adults required dialysis for acute renal failure. A retrospective cohort of inpatients receiving parenteral ketorolac and opioids for two days showed that the ketorolac group were at no greater risk of acute renal failure compared to the opioid group (adjusted relative risk= 0.86, 95% CI: 0.63 to 1.17) 2 . However, it is plausible that NSAIDs may cause postoperative renal failure in patients with pre-existing impaired renal blood flow, such as the elderly, those with heart failure or shock, or patients exposed to other nephrotoxic agents 5 . Jaquenod and colleagues showed that severe renal dysfunction with widespread histological changes of acute tubular necrosis occurred in laparotomized rats given both gentamicin and ketorolac, but not in rats 578 A. LEE, M. COOPER ET AL Anaesthesia and Intensive Care, Vol. 27, No. 6, December 1999 given ketorolac alone with or without adequate hydration 34 . Restriction of fluids in the early postoperative period, combined with a possible stress response, led to a significant transient reduction in urine output in patients given diclofenac compared to placebo 13 . None of the patients included in the trials was recorded as receiving preoperative hydration treatment. Dehydration was a possible contributory factor in several case reports of ketorolac-associated renal dysfunction, because it may have predisposed the kidneys to rely on increased prostaglandin synthesis 34 . Consideration should be given to maintaining adequate fluid balance in patients following surgery.
Caution is needed in interpreting the results of a meta-analysis that is exclusively based on the results of several small trials. First, publication bias can distort the results of a meta-analysis because small positive trials are more likely to be published than negative ones 35 . This systematic review was based on published studies only. A standard method to assess the presence of publication bias is to construct a funnel plot 25 . In this paper, we were unable to construct a funnel plot because there were insufficient number of trials to do so. Second, while the trials included in this systematic review were all double-blinded, the allocation concealment was unclear in most trials. Compared with trials with adequate allocation concealment, trials with unclear allocation concealment have been shown to exaggerate the treatment effect by 30% 23 . Therefore, both publication bias and allocation concealment issues may have led to an exaggeration of treatment effect in this meta-analysis.
A limitation of this study was the use of several surrogate measures of renal function for postoperative renal failure. These renal function tests have varying sensitivity and specificity for predicting the onset of perioperative renal dysfunction 36 . While serial determination of creatinine clearance is one of the most sensitive tests for predicting the onset of perioperative renal dysfunction 36 , creatinine clearance involving urine collections over 24 hours overestimates the glomerular filtration rate by 13% 37 . This confirms our view that the reduction in creatinine clearance was clinically unimportant. As testing creatinine clearance is time-consuming and labour intensive 36 , few studies included in this systematic review collected creatinine clearance for more than a day. Aitken et al 12 and Power et al 14 studies suggest that there was a trend towards normal renal function on the second day after surgery after the use of NSAIDs.
Another consideration is that there were in-sufficient studies to explore the reduction in postoperative renal function according to the type of NSAIDs by subgroup analysis. The different NSAIDs were combined to assess the overall adverse renal effects caused by this class of drugs and there was no evidence of statistical heterogeneity between the studies. All trials used the recommended maximum doses of NSAIDs in adults with normal baseline renal function. A direct comparison between diclofenac and ketorolac in a recent trial showed that both had similar minor effects on serum creatinine 19 . This finding provides strong evidence that these NSAIDs have similar adverse renal effects. We are confident that the conclusions drawn from this systematic review can be applied to individual NSAIDs. Recent work suggests that different types of NSAIDs inhibit cyclo-oxygenase-1 (COX-1) and cyclo-oxygenase-2 (COX-2) to a varying extent 38 . COX-1 is responsible for the production of prostaglandins in all tissues, while COX-2 is expressed only after trauma or inflammation 39 . NSAIDs that have a high COX-2: COX-1 ratio may have more potent antiinflammatory activity with fewer side-effects than drugs with lower COX-2: COX-1 ratio 39 . Further work is required to assess whether COX-2 selective inhibitors offer more benefits for patients with renal disease or those at risk of NSAID-induced renal dysfunction.
While the use of NSAIDs as sole analgesics has not been justified, the efficacy of NSAIDs as components of multimodal analgesia has been confirmed 40 . In considering the adverse renal effects of NSAIDs, this systematic review has shown that there was a clinically unimportant transient reduction in renal function in the early postoperative period in a wide variety of surgical settings. It should be noted that our findings may not be transferable to children, in whom the renal effects of postoperative NSAIDs have not been adequately studied. We conclude that NSAIDs should not be withheld from adults with normal preoperative renal function because of concerns about postoperative renal impairment, but adequate perioperative hydration should be ensured.
